Core Scientific Common Stock Performance
| CORZ Stock | USD 18.08 0.05 0.28% |
The firm shows a Beta (market volatility) of 0.55, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Core Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Core Scientific is expected to be smaller as well. Core Scientific Common right now shows a risk of 4.22%. Please confirm Core Scientific Common value at risk, as well as the relationship between the kurtosis and price action indicator , to decide if Core Scientific Common will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Core Scientific Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Core Scientific is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.61) | Five Day Return 6.04 | Year To Date Return 12.07 | Ten Year Return 420.93 | All Time Return 420.93 |
1 | Core Scientific, OpenAI named in worker comp lawsuit alleging transformer explosion | 10/31/2025 |
2 | Jim Cramer Grills CoreWeave CEO Over Data Center Delays Despite 55.6 Billion Backlog | 11/12/2025 |
3 | Core Scientific, Inc. CORZ Shares Acquired by Prudential Financial Inc. | 12/03/2025 |
4 | Fund Adds 25 Million to Core Scientific Stake Weeks Before a Nearly 40 percent Selloff | 12/17/2025 |
5 | Core Scientific Gets 7.3 percent Boost from Buy Reco | 12/19/2025 |
6 | Wall Street Sees More Than 69 percent Upside for Core Scientific Inc. | 12/23/2025 |
7 | Disposition of 40100 shares by Rozov Yadin of Core Scientific subject to Rule 16b-3 | 12/30/2025 |
8 | A 116 Million Bet on Core Scientific Signals Conviction Beyond Bitcoin Cycles and Headline Volatility | 12/31/2025 |
9 | Spotlight on Core Scientific Analyzing the Surge in Options Activity | 01/05/2026 |
10 | Core Scientific Valuation Check As AI Pivot And Analyst Upgrade Draw Fresh Attention | 01/07/2026 |
| Begin Period Cash Flow | 69.7 M | |
| Total Cashflows From Investing Activities | -95.2 M |
Core Scientific Relative Risk vs. Return Landscape
If you would invest 1,900 in Core Scientific Common on October 17, 2025 and sell it today you would lose (92.00) from holding Core Scientific Common or give up 4.84% of portfolio value over 90 days. Core Scientific Common is currently generating 0.008% in daily expected returns and assumes 4.2207% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Core, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Core Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Core Scientific Common, and traders can use it to determine the average amount a Core Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0019
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CORZ |
Based on monthly moving average Core Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Core Scientific by adding Core Scientific to a well-diversified portfolio.
Core Scientific Fundamentals Growth
Core Stock prices reflect investors' perceptions of the future prospects and financial health of Core Scientific, and Core Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Core Stock performance.
| Return On Asset | -0.0606 | ||||
| Profit Margin | (2.30) % | ||||
| Operating Margin | (0.60) % | ||||
| Current Valuation | 6.3 B | ||||
| Shares Outstanding | 310.06 M | ||||
| Price To Sales | 16.73 X | ||||
| Revenue | 510.67 M | ||||
| Gross Profit | 34.13 M | ||||
| EBITDA | (1.16 B) | ||||
| Net Income | (1.32 B) | ||||
| Cash And Equivalents | 29.55 M | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 1.2 B | ||||
| Current Ratio | 0.17 X | ||||
| Book Value Per Share | (3.66) X | ||||
| Cash Flow From Operations | 42.9 M | ||||
| Earnings Per Share | (2.16) X | ||||
| Market Capitalization | 5.59 B | ||||
| Total Asset | 1.6 B | ||||
| Retained Earnings | (3.74 B) | ||||
| Working Capital | 769.4 M | ||||
About Core Scientific Performance
Evaluating Core Scientific's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Core Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Core Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.95) | (0.99) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.95) | (0.99) | |
| Return On Equity | 1.44 | 0.95 |
Things to note about Core Scientific Common performance evaluation
Checking the ongoing alerts about Core Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Core Scientific Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Core Scientific had very high historical volatility over the last 90 days | |
| Core Scientific has a very high chance of going through financial distress in the upcoming years | |
| Core Scientific Common currently holds 1.2 B in liabilities. Core Scientific Common has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Core Scientific's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 510.67 M. Net Loss for the year was (1.32 B) with profit before overhead, payroll, taxes, and interest of 34.13 M. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Core Scientific Valuation Check As AI Pivot And Analyst Upgrade Draw Fresh Attention |
- Analyzing Core Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Core Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Core Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Core Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Core Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Core Scientific's stock. These opinions can provide insight into Core Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Core Stock Analysis
When running Core Scientific's price analysis, check to measure Core Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific is operating at the current time. Most of Core Scientific's value examination focuses on studying past and present price action to predict the probability of Core Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific's price. Additionally, you may evaluate how the addition of Core Scientific to your portfolios can decrease your overall portfolio volatility.